Disease activity and damage in juvenile idiopathic arthritis: methotrexate era versus biologic era

被引：0
|
作者：
Gabriella Giancane
Valentina Muratore
Valentina Marzetti
Neus Quilis
Belen Serrano Benavente
Francesca Bagnasco
Alessandra Alongi
Adele Civino
Lorenzo Quartulli
Alessandro Consolaro
Angelo Ravelli
机构：
[1] Università degli Studi di Genova,Dipartimento di Neuroscienze, Riabilitazione, Oftalmologia, Genetica e Scienze Materno
[2] IRCCS G. Gaslini,Infantili
[3] IRCCS Fondazione Policlinico San Matteo,Clinica Pediatrica e Reumatologia
[4] Ospedale Vito Fazzi,Clinica Pediatrica
[5] Azienda Ospedaliera Cardinale G. Panico,UOC Pediatria
[6] Sechenov First Moscow State Medical University,undefined
来源：
Arthritis Research & Therapy | / 21卷
关键词：
Juvenile idiopathic arthritis; Disease activity; Disease damage; Long-term outcome; Methotrexate; Biologic agents;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Cytokine Biomarkers of Disease Activity and Therapeutic Response after Initiating Methotrexate Therapy in Patients with Juvenile Idiopathic Arthritis
    Funk, Ryan S.
    Chan, Marcia A.
    Becker, Mara L.
    PHARMACOTHERAPY, 2017, 37 (06): : 700 - 711
  • [32] Adherence to methotrexate in juvenile idiopathic arthritis
    Pelajo, Christina F.
    Sgarlat, Caitlin M.
    Lopez-Benitez, Jorge M.
    Oliveira, Sheila K. F.
    Rodrigues, Marta C. F.
    Sztajnbok, Flavio R.
    Diniz, Christianne C.
    Miller, Laurie C.
    RHEUMATOLOGY INTERNATIONAL, 2012, 32 (02) : 497 - 500
  • [33] Genetic determinants for methotrexate response in juvenile idiopathic arthritis
    Pastore, Serena
    Stocco, Gabriele
    Favretto, Diego
    De Ludicibus, Sara
    Taddio, Andrea
    d'Adamo, Pio
    Malusa, Noelia
    Addobbati, Riccardo
    Decorti, Giuliana
    Lepore, Loredana
    Ventura, Alessandro
    FRONTIERS IN PHARMACOLOGY, 2015, 6
  • [34] Prognostic factors in rheumatoid arthritis in the era of biologic agents
    Skapenko, Alla
    Prots, Iryna
    Schulze-Koops, Hendrik
    NATURE REVIEWS RHEUMATOLOGY, 2009, 5 (09) : 491 - 496
  • [35] Trends towards more active introduction of drug therapy, emphasizing methotrexate and biologic agents, for juvenile idiopathic arthritis
    Heini Pohjankoski
    Hannu Kautiainen
    Juhani Virta Lauri
    Kari Puolakka
    Vappu Rantalaiho
    Clinical Rheumatology, 2020, 39 : 263 - 268
  • [36] Final validation of a new composite disease activity score for juvenile idiopathic arthritis: the Juvenile Arthritis Disease Activity Score (JADAS)
    A Consolaro
    N Ruperto
    A Bazso
    S Magni-Manzoni
    MA Pelagatti
    A Pistorio
    A Magnani
    C Malattia
    I D'Agostino
    G Filocamo
    A Martini
    A Ravelli
    Pediatric Rheumatology, 6 (Suppl 1)
  • [37] PET assessment of disease activity in children with juvenile idiopathic arthritis
    Ukihide Tateishi
    Tomoyuki Imagawa
    Noriko Kanezawa
    Tetsuhiko Okabe
    Kazuya Shizukuishi
    Tomio Inoue
    Shumpei Yokota
    Pediatric Radiology, 2010, 40 : 1781 - 1788
  • [38] PET assessment of disease activity in children with juvenile idiopathic arthritis
    Tateishi, Ukihide
    Imagawa, Tomoyuki
    Kanezawa, Noriko
    Okabe, Tetsuhiko
    Shizukuishi, Kazuya
    Inoue, Tomio
    Yokota, Shumpei
    PEDIATRIC RADIOLOGY, 2010, 40 (11) : 1781 - 1788
  • [39] Impaired cardiorespiratory and neuromuscular fitness in children and adolescents with juvenile idiopathic arthritis: a cross-sectional case–control study in the era of biologic drug therapies
    Kati Räsänen
    Kati Markula-Patjas
    Saija Kantanen
    Kalle Sipilä
    Timo A. Lakka
    Pekka Arikoski
    Eija Piippo-Savolainen
    Pediatric Rheumatology, 21
  • [40] A controversial topic in juvenile idiopathic arthritis: Association between biologic agents and malignancy
    Koker, Oya
    Sahin, Sezgin
    Adrovic, Amra
    Yildiz, Mehmet
    Barut, Kenan
    Gulle, Bugra
    Eker Omeroglu, Rukiye
    Kasapcopur, Ozgur
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2020, 23 (09) : 1210 - 1218
12345